These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23765176)

  • 1. Serial magnetic resonance imaging for monitoring medical therapy effects in Crohn's disease.
    Tielbeek JA; Löwenberg M; Bipat S; Horsthuis K; Ponsioen CY; D'Haens GR; Stoker J
    Inflamm Bowel Dis; 2013 Aug; 19(9):1943-50. PubMed ID: 23765176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.
    Thomassin L; Armengol-Debeir L; Charpentier C; Bridoux V; Koning E; Savoye G; Savoye-Collet C
    World J Gastroenterol; 2017 Jun; 23(23):4285-4292. PubMed ID: 28694669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
    BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapy.
    Schaeffer DF; Walsh JC; Kirsch R; Waterman M; Silverberg MS; Riddell RH
    Hum Pathol; 2014 Sep; 45(9):1928-35. PubMed ID: 25022570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease.
    van Rijn KL; Lansdorp CA; Tielbeek JAW; Nio CY; Buskens CJ; D'Haens GRAM; Löwenberg M; Stoker J
    Clin Imaging; 2020 Feb; 59(2):179-187. PubMed ID: 31821976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas.
    Tozer P; Ng SC; Siddiqui MR; Plamondon S; Burling D; Gupta A; Swatton A; Tripoli S; Vaizey CJ; Kamm MA; Phillips R; Hart A
    Inflamm Bowel Dis; 2012 Oct; 18(10):1825-34. PubMed ID: 22223472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography enterography detects intestinal wall changes and effects of treatment in patients with Crohn's disease.
    Bruining DH; Loftus EV; Ehman EC; Siddiki HA; Nguyen DL; Fidler JL; Huprich JE; Mandrekar JN; Harmsen WS; Sandborn WJ; Fletcher JG
    Clin Gastroenterol Hepatol; 2011 Aug; 9(8):679-683.e1. PubMed ID: 21621641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn's fistulas.
    Ng SC; Plamondon S; Gupta A; Burling D; Kamm MA
    Aliment Pharmacol Ther; 2009 Oct; 30(7):757-66. PubMed ID: 19575762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity.
    Eder P; Katulska K; Krela-Kaźmierczak I; Stawczyk-Eder K; Klimczak K; Szymczak A; Linke K; Łykowska-Szuber L
    Abdom Imaging; 2015 Oct; 40(7):2210-8. PubMed ID: 26048698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
    Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease.
    Van Assche G; Herrmann KA; Louis E; Everett SM; Colombel JF; Rahier JF; Vanbeckevoort D; Meunier P; Tolan D; Ernst O; Rutgeerts P; Vermeire S; Aerden I; Oortwijn A; Ochsenkühn T
    J Crohns Colitis; 2013 Dec; 7(12):950-7. PubMed ID: 23411006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fistulizing perianal Crohn's disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy.
    Savoye-Collet C; Savoye G; Koning E; Dacher JN; Lerebours E
    Inflamm Bowel Dis; 2011 Aug; 17(8):1751-8. PubMed ID: 21744430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report.
    Feagan BG; Lémann M; Befrits R; Connell W; D'Haens G; Ghosh S; Michetti P; Ochsenkühn T; Panaccione R; Schreiber S; Silverberg M; Sorrentino D; van der Woude CJ; Vermeire S; Rutgeerts P
    Inflamm Bowel Dis; 2012 Jan; 18(1):152-60. PubMed ID: 22038857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep remission on magnetic resonance imaging impacts outcomes of perianal fistulizing Crohn's disease.
    Chambaz M; Verdalle-Cazes M; Desprez C; Thomassin L; Charpentier C; Grigioni S; Armengol-Debeir L; Bridoux V; Savoye G; Savoye-Collet C
    Dig Liver Dis; 2019 Mar; 51(3):358-363. PubMed ID: 30612820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients.
    Olbjørn C; Nakstad B; Småstuen MC; Thiis-Evensen E; Vatn MH; Perminow G
    Scand J Gastroenterol; 2014 Dec; 49(12):1425-31. PubMed ID: 25310799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy.
    Leal RF; Planell N; Kajekar R; Lozano JJ; Ordás I; Dotti I; Esteller M; Masamunt MC; Parmar H; Ricart E; Panés J; Salas A
    Gut; 2015 Feb; 64(2):233-42. PubMed ID: 24700437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Campos C; Perrey A; Lambert C; Pereira B; Goutte M; Dubois A; Goutorbe F; Dapoigny M; Bommelaer G; Hordonneau C; Buisson A
    Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I; Faubion WA
    Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tumour necrosis factor antagonists in stricturing Crohn's disease: A tertiary center real-life experience.
    Allocca M; Bonifacio C; Fiorino G; Spinelli A; Furfaro F; Balzarini L; Bonovas S; Danese S
    Dig Liver Dis; 2017 Aug; 49(8):872-877. PubMed ID: 28416240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring Crohn's disease during anti-TNF-α therapy: validation of the magnetic resonance enterography global score (MEGS) against a combined clinical reference standard.
    Prezzi D; Bhatnagar G; Vega R; Makanyanga J; Halligan S; Taylor SA
    Eur Radiol; 2016 Jul; 26(7):2107-17. PubMed ID: 26433956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.